Arkolith/Insider Trading/GLUE/Form 4

Janku Filip

Chief Medical OfficerMonte Rosa Therapeutics, Inc. (GLUE) · full profile →Form 4 · filed Jun 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$882K
Net Open-Market Flow
-$882K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)30K$7.56$227K90K
Jun 24, 2026Sell(S)30K$21.42$643K60K
Jun 23, 2026Option exercise(M)6K$7.56$45K72K
Jun 23, 2026Sell(S)12K$20.22$240K60K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 24, 2026Option exercise(M)30K—$066K
Jun 23, 2026Option exercise(M)6K—$096K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-282740) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML